LL-37 regulates the overexpression of vascular endothelial growth factor (VEGF) and c-IAP-2 in human keratinocytes.
about
Recombinant adeno-associated virus delivered human thioredoxin-PR39 prevents hypoxia-induced apoptosis of ECV304 cells.Potential role of recombinant adeno-associated virus human thioredoxin-PR39 in cell and vascular protection against hypoxiaCross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis.Dermasence refining gel modulates pathogenetic factors of rosacea in vitro.Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer.Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing.Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics.Pathogenesis and clinical presentation of rosacea as a key for a symptom-oriented therapy.Pathogenese und Klinik der Rosazea als Schlüssel für eine symptomorientierte Therapie.Peptidoglycan from Staphylococcus aureus has an anti-apoptotic effect in HaCaT keratinocytes mediated by the production of the cellular inhibitor of apoptosis protein-2.Cathelicidin PR-39 peptide inhibits hypoxia/reperfusion-induced kidney cell apoptosis by suppression of the endoplasmic reticulum-stress pathway.Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial.EPR monitoring of wound oxygenation as a biomarker of response to gene therapy encoding hCAP-18/LL37 peptide.Polymorphism in cathelicidin gene (CAMP) that alters Hypoxia-inducible factor (HIF-1α::ARNT) binding is not associated with tuberculosis.
P2860
Q35139416-E4E6BF93-7B52-45BF-9B1D-526AD660B719Q35754188-AC2E8FDE-395A-4B71-B978-EADC28F25D44Q35763195-67F798A2-C280-4725-9164-C15F449F6112Q36325038-AD869D02-819F-4103-BC42-D63F0AC6FFB1Q37205544-15C3A4A0-28EC-4BD6-A986-11E14159A742Q37532896-7CBD2B64-0E12-453D-B73D-B7813DB12B59Q37696015-9B8E7149-2B27-47BE-88AA-4399F0317438Q38885566-92E2EA89-9905-4748-ACDD-7D9BAF0C8737Q39015127-1358871B-504E-4DEB-82F1-019B57F021FBQ39015145-37E609F1-8718-496A-B2FA-AA2B0F967CB0Q39039106-4E7F101F-73F2-46A5-8491-ADB4107413DCQ39648006-2EE542A7-D321-44DC-AF82-1EE7345A0C95Q42672939-6222C600-B886-4A68-918F-5BE623F9E312Q45872848-D8A37022-8AAF-4B47-A8DC-91C81D3EA0E0Q47760931-7DF8C118-8A5B-4BC5-B582-30FADB462070
P2860
LL-37 regulates the overexpression of vascular endothelial growth factor (VEGF) and c-IAP-2 in human keratinocytes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
LL-37 regulates the overexpres ...... -IAP-2 in human keratinocytes.
@en
LL-37 regulates the overexpression of vascular endothelial growth factor
@nl
type
label
LL-37 regulates the overexpres ...... -IAP-2 in human keratinocytes.
@en
LL-37 regulates the overexpression of vascular endothelial growth factor
@nl
prefLabel
LL-37 regulates the overexpres ...... -IAP-2 in human keratinocytes.
@en
LL-37 regulates the overexpression of vascular endothelial growth factor
@nl
P2093
P2860
P1476
LL-37 regulates the overexpres ...... -IAP-2 in human keratinocytes.
@en
P2093
Juan Carlos Cancino-Diaz
Luis Martin Vargas-Zuñiga
Mario Eugenio Cancino-Diaz
Sandra Rodríguez-Martínez
P2860
P304
P356
10.1111/J.1365-4632.2008.03340.X
P577
2008-05-01T00:00:00Z